Enfusion Ownership

Enfusion retains a total of 91.91 Million outstanding shares. The majority of Enfusion outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Enfusion to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Enfusion. Please pay attention to any change in the institutional holdings of Enfusion as this could imply that something significant has changed or is about to change at the company. Also note that almost three million six hundred seventy-six thousand four hundred fifty-six invesors are currently shorting Enfusion expressing very little confidence in its future performance. Some institutional investors establish a significant position in stocks such as Enfusion in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Enfusion, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. As of the 3rd of June 2024, Dividend Yield is likely to grow to 0, while Dividends Paid is likely to drop 0.00. As of the 3rd of June 2024, Common Stock Shares Outstanding is likely to drop to about 111.4 M. In addition to that, Net Loss is likely to drop to about (7.2 M). Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.